Abiopharma

Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer

Novavaxs H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Vir Biotechnology - Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors

Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors

Water Tower Research Highlights Ainos SmellTech Platform AI Nose as Foundational AI Innovation

Integer Holdings Corporation - Integer Holdings Corporation Reports Second Quarter 2025 Results

BioVie Inc. - BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology

Bausch Health Notification

Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s

Johnson & Johnson - Johnson & Johnson showcases latest advancements in Alzheimers research at AAIC 2025